Literature DB >> 21846582

Protection in a hamster model of congenital toxoplasmosis.

A Freyre1, F A P Araujo, C G Fialho, L E Bigatti, J D Falcón.   

Abstract

Almost uniform protection against congenital toxoplasmosis initiated by inoculations with cysts and oocysts of the parasite was seen in the hamster model, among strains of different genotypes. Because the RH immunization prior to pregnancy has to be controlled with medication for most of the hamsters to survive, and also some congenital transmission of Toxoplasma was observed during the chronic stage of the infection, the hamster is considered less practical than the rat and the BALB/c mouse models. It is concluded that the hamster model closely resembles protection against congenital infection in nature, where most of the pregnant women and ewes that experienced a toxoplasma infection previously, protect their fetuses against an infection with the parasite during pregnancy.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21846582     DOI: 10.1016/j.vetpar.2011.07.039

Source DB:  PubMed          Journal:  Vet Parasitol        ISSN: 0304-4017            Impact factor:   2.738


  3 in total

Review 1.  Maternal vaccination: moving the science forward.

Authors:  Azure N Faucette; Benjamin L Unger; Bernard Gonik; Kang Chen
Journal:  Hum Reprod Update       Date:  2014-07-11       Impact factor: 15.610

Review 2.  Vaccines in Congenital Toxoplasmosis: Advances and Perspectives.

Authors:  Mariana Barros; Daniela Teixeira; Manuel Vilanova; Alexandra Correia; Natercia Teixeira; Margarida Borges
Journal:  Front Immunol       Date:  2021-02-15       Impact factor: 7.561

3.  Congenital Toxoplasmosis in Chronically Infected and Subsequently Challenged Ewes.

Authors:  Thaís Rabelo Dos Santos; Gabriela da Silva Magalhães Faria; Bruna Martins Guerreiro; Nathalia Helena Pereira da Silva Dal Pietro; Welber Daniel Zanetti Lopes; Helenara Machado da Silva; João Luis Garcia; Maria Cecília Rui Luvizotto; Katia Denise Saraiva Bresciani; Alvimar José da Costa
Journal:  PLoS One       Date:  2016-10-27       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.